Cargando…
Plasma ST6GAL1 regulates IgG sialylation to control IgA nephropathy progression
BACKGROUND: Our previous study revealed that plasma levels of a-2,6-sialyltransferase 1 (ST6GAL1) were increased in patients with IgA nephropathy (IgAN). ST6GAL1 catalyzes terminal sialylation of IgG to shift the antibody effector function to the anti-inflammatory pattern. However, the role of plasm...
Autores principales: | Liu, Youxia, Yu, Huyan, Wu, Sijing, Yang, Xia, Cao, Congcong, Wang, Fanghao, Jia, Junya, Yan, Tiekun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8516375/ https://www.ncbi.nlm.nih.gov/pubmed/34729155 http://dx.doi.org/10.1177/20406223211048644 |
Ejemplares similares
-
Sialylation of IgG inhibits the formation of galactose-deficient IgA1-containing immune complexes and protects mesangial cells from injury in IgA nephropathy
por: Liu, Youxia, et al.
Publicado: (2022) -
ST6Gal1 is up‐regulated and associated with aberrant IgA1 glycosylation in IgA nephropathy: An integrated analysis of the transcriptome
por: Liu, Youxia, et al.
Publicado: (2020) -
Elevated activating Fc gamma receptors levels correlated with susceptibility and severity of IgA nephropathy
por: Li, Hongfen, et al.
Publicado: (2022) -
ELL2 Is Downregulated and Associated with Galactose-Deficient IgA1 in IgA Nephropathy
por: Liu, Youxia, et al.
Publicado: (2019) -
Comprehensive analysis of aberrantly expressed profiles of mRNA and its relationship with serum galactose-deficient IgA1 level in IgA nephropathy
por: Liu, Youxia, et al.
Publicado: (2019)